Alturas Analytics provides LC-MS/MS services that help organizations make confident decisions during all stages of drug development. Our LC-MS/MS platforms generate precise and reliable submission-ready data for small-molecule and complex therapeutic programs during all stages from early-stage assay development to regulated clinical sample analysis.

Our quantitative expertise prepares your data for regulatory review when you are developing new chemical entities.

Scientist working in bioanalytical LC-MS/MS laboratory.

Comprehensive LC-MS/MS Services from Discovery Through NDA

Our scientists assist your project throughout feasibility evaluation, formal method validation, and clinical execution. The LC-MS/MS services at Alturas include:

  • Custom method development and validation aligned with global guidance
  • Trace-level quantitation of drug compounds, metabolites, and biomarkers
  • High-throughput sample preparation for consistent results
  • Incurred sample reanalysis (ISR) and full data integrity assurance

Learn More: Development and Validation of LC-MS/MS Methods

Expertise Across Molecules and Modalities

The laboratory at Alturas Analytics provides analytical support for various biological samples and chemical compounds. We provide:

  • Assay support for small molecules, peptides, and biologics
  • LC-MS/MS-based workflows that adapt to high-complexity studies

Our team demonstrates exceptional ability to handle extraction variations and method transfers between development and regulated environments.

Instrumentation and Platform Capabilities

Our lab uses industry-standard instrumentation configured for accuracy, precision, and throughput.

Explore Our Tech Focus: Alturas Analytics Instrumentation

Regulatory Compliance and Method Validation

Alturas Analytics operates under GLP compliance and follows ICH M10 guidance for method validation and data reporting procedures. We offer:

  • Selectivity, sensitivity, accuracy, and reproducibility assessments
  • Audit-ready documentation for regulatory agencies

Explore More: Alturas Analytics Quality

Why Alturas for LC-MS/MS Services

  • Dedicated study leads and regulatory support
  • Proven success supporting INDs, NDAs, and global submissions
  • Seamless integration with PK/TK and method development workflows

Related Project: GC-MS/MS Tuberculosa Case Study

HRMS/MS

Our HRMS capabilities support both qualitative and quantitative workflows—ideal for protein quantitation, metabolite identification, biomarker discovery, and non-targeted screening delivering precise mass accuracy and robust sensitivity to provide deeper insight across discovery and regulated studies.

GC-MS/MS Analytical Services for Specialized Detection

The GC-MS/MS technology at Alturas Analytics delivers sensitive and selective detection methods for detecting volatile semi-volatile and thermally unstable compounds. Scientists from our team employ GC-MS/MS techniques when LC-MS/MS methods are inappropriate to achieve complete detection of substances across therapeutic programs.

GC-MS/MS services at Alturas include:

  • Quantitative analysis of volatile and semi-volatile organic compounds
  • The method detects trace amounts of impurities alongside metabolites and biomarkers in samples.
  • The method supports testing samples from plasma urine breath and tissue extracts across different matrices.
  • Specialized workflows for environmental and stability-related studies
  • Our team performs GLP-compliant method development and validation according to regulatory guidance.

GC-MS/MS Applications:

  • The analysis of low molecular weight drugs and their metabolites falls under this category
  • Chiral separations and impurity profiling
  • Biomarker validation and metabolic pathway studies

Why GC-MS/MS with Alturas?

  • The expanded capabilities enable the analysis of compounds that are not suitable for LC-MS/MS procedures.
  • The company possesses a successful history of regulatory submissions that require GC-MS/MS data collection.
  • The combination of LC-MS/MS with PK/TK workflows along with this method provides complete bioanalytical support.

Internal Links

Quantitative Analysis of Cotinine in Human Plasma and Urine Utilizing a Simple Supported Liquid/Liquid Exchange Extraction and GC-MS/MS


Frequently Asked Questions


The M10 bioanalytical method validation guidance requires our laboratory to perform accuracy and precision, as well as selectivity, sensitivity, and reproducibility checks.

Yes. Bioanalytical data generated at Alturas is GLP-compliant and ready for submission to the FDA, EMA, and other regulatory bodies.


Request an LC-MS/MS Project Consultation

Need defensible, fast-turnaround LC-MS/MS support for your drug development program?

The first step to start a data-driven partnership with an Alturas Analytics scientist begins with requesting a consultation.


Internal Links:

Bioanalytical Services

PK/TK Service

Method Development and Validation


Speak with an Expert

Headshot of Chad Christianson.

Chad Christianson

Analytical Development Manager

Chad has over 24 years of related experience as an analytical scientist with over 20 years focused on bioanalysis at Alturas Analytics. Chad is responsible for supervision of the analytical method development team in supporting method validations and sample analysis and Study Director/Principal Investigator on GLP and clinical studies, providing technical oversight to clients across all therapeutic areas.

"*" indicates required fields

Let us know how we can help. Please be specific.